(EMAILWIRE.COM, April 13, 2020 ) The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.

At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Immunoprecipitation Market. We are working diligently to help companies take rapid decisions by studying:

The impact of COVID-19 on the Immunoprecipitation Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
The rapid shifts in the strategies of the Top 50 companies in the Immunoprecipitation Market
The shifting short-term priorities of the top 50 companies’ clients and their client’s clients
You can request an in-depth analysis detailing the impact of COVID-19 on the Immunoprecipitation Market:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=78538655

The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases).

Immunoprecipitation Market Growth — Expected to grow from USD 560 million in 2018 to USD 750 million by 2024, at a CAGR of 5.0%.

The kits segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this market can be attributed to factors such as the requirement for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens.

The individual IP segment is projected to grow at the highest rate in the market, by type. The increasing use of IP in studying protein-protein interactions, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies during the forecast period.

Geographical Region Covered under Immunoprecipitation Market.

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78538655

Key Players of Immunoprecipitation Market

Major immunoprecipitation vendors include Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad Laboratories (US), Merck KGaA (Germany), GenScript. (US), and BioLegend (US), Cell Signaling Technology (US), Rockland Immunochemicals (US), Takara Bio (Japan), and Geno Technology (US).